TN
Thejeswar N Prakasham
Nizam's Institute of Medical Sciences, Apollo Institute of Medical Sciences and Research Hyderabad, Jawaharlal Institute of Post Graduate Medical Education and Research, Indian Redcross Cancer center
Employment
-
Nizam's Institute of Medical Sciences Assistant professor2024 - Present
-
Apollo Institute of Medical Sciences and Research Hyderabad Assistant professor2023 - 2024
-
Indian Redcross Cancer center Consultant2022 - 2023
-
Regional Cancer Centre JIPMER Senior Resident2019 - 2022
Education
-
Jawaharlal Institute of Post Graduate Medical Education and Research DM (Medical oncology)2019 - 2022
-
All India Institute of Medical Sciences MD2014 - 2016
-
Kurnool Medical College MBBS2007 - 2012
Projects & Funding
Projects & funding information is unavailable.
Publications (19)
- Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Save
- Levofloxacin Prophylaxis During Acute Leukaemia Induction Chemotherapy: A Prospective Randomized Study of Infectious Outcomes Save
- Less‑intensive therapy in newly diagnosed acute myeloid leuekmia (AML) in India: Real-world adoption and prognostic utility of ELN‑LI and ELN‑2022 classification Save
- Pediatric inspired (BFM) protocol in adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL) in India: Real‑world treatment timelines and impact of delays on survival Save
- Prognostic utility of the ELTS score in pediatric chronic myeloid leukemia: Is it a valid clinical tool? Save
- Bone Marrow and Kidney Findings at Odds: A Case Report and Review of Literature of Divergent Pathology in Chronic Myeloid Leukemia Save
- Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia-Blast Phase: A Single-Center Experience from South India Save
- Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Save
- Zoledronic acid in combination with standard neoadjuvant anthracycline and taxane-based chemotherapy regimen in patients with early and locally advanced triple-negative breast cancer – A single-arm open-label phase II study (ZACT) Save
- Systemic Immune-Inflammation Index Predicts Outcomes in Platinum-Resistant Relapsed Ovarian Cancer Save